BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19858775)

  • 21. Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
    Garat CV; Crossno JT; Sullivan TM; Reusch JE; Klemm DJ
    J Cardiovasc Pharmacol; 2010 May; 55(5):469-80. PubMed ID: 20147842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.
    Mermis J; Gu H; Xue B; Li F; Tawfik O; Buch S; Bartolome S; O'Brien-Ladner A; Dhillon NK
    Respir Res; 2011 Aug; 12(1):103. PubMed ID: 21819559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure.
    Zychowski KE; Lucas SN; Sanchez B; Herbert G; Campen MJ
    Toxicol Appl Pharmacol; 2016 Aug; 305():40-45. PubMed ID: 27286659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
    Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
    Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
    Casey DB; Badejo AM; Dhaliwal JS; Sikora JL; Fokin A; Golwala NH; Greco AJ; Murthy SN; Nossaman BD; Hyman AL; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H184-92. PubMed ID: 20435851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-dependent changes in the pulmonary vasoconstriction potential of newborn rats following short-term oxygen exposure.
    Enomoto M; Gosal K; Cubells E; Escobar J; Vento M; Jankov RP; Belik J
    Pediatr Res; 2012 Nov; 72(5):468-78. PubMed ID: 22926548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Hanson SFL; Terry MH; Moretta DT; Power GG; Wilson SM; Alam F; Ahsan F; Blood AB; Giri PC
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):472-480. PubMed ID: 29756460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
    Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
    Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
    Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung.
    Parker TA; Roe G; Grover TR; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L976-82. PubMed ID: 16815887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.
    Fujita H; Fukumoto Y; Saji K; Sugimura K; Demachi J; Nawata J; Shimokawa H
    Heart Vessels; 2010 Mar; 25(2):144-9. PubMed ID: 20339976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Sun XZ; Tian XY; Wang DW; Li J
    Eur Rev Med Pharmacol Sci; 2014; 18(7):959-64. PubMed ID: 24763873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rho-kinase inhibitors augment the inhibitory effect of propofol on rat bronchial smooth muscle contraction.
    Hanazaki M; Yokoyama M; Morita K; Kohjitani A; Sakai H; Chiba Y; Misawa M
    Anesth Analg; 2008 Jun; 106(6):1765-71. PubMed ID: 18499607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.